Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Di

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
ACS Applied Materials & Interfaces|August 1, 2019
Bismuth Vacancy-Tuned Bismuth Oxybromide Ultrathin Nanosheets toward Photocatalytic CO<sub>2</sub> ReductionJun Di, Chao Chen, Chao Zhu, et al.
Scientific Reports|April 2, 2024
B-Myb deficiency boosts bortezomib-induced immunogenic cell death in colorectal cancerYuan-Jian Hui, Ting-Ting Yu, Liu-Gen Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 24, 2020
A Tandem 0D/2D/2D NbS<sub>2</sub> Quantum Dot/Nb<sub>2</sub> O<sub>5</sub> Nanosheet/g-C<sub>3</sub> N<sub>4</sub> Flake System with Spatial Charge-Transfer Cascades for Boosting Photocatalytic Hydrogen EvolutionBo Lin, Zihao Chen, Pin Song, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitroXiao-Lin Lin, Xiao-Li Wang, Bo Ma, et al.
Experimental & Molecular Medicine|March 14, 2026
NRIP1 disrupts ERα signal in Sjögren's disease via AQP5 suppression and MYC-driven salivary dysfunctionBo Chen, Janak L Pathak, Xiuni Qin, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 24, 2003
[Phase II clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer]Shu-jun Liu, Li-jun Di, Jie Wang, et al.
The Journal of International Medical Research|January 12, 2023
The inflammatory cytokine profiles and ocular biometric characteristics of primary angle-closure glaucomaHong-Bo Zeng, Jun-Di Jiang, Rong Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 6, 2006
[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer]Lin Yang, Jin-wan Wang, Yan Sun, et al.
Photodiagnosis and Photodynamic Therapy|April 8, 2023
Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancerYuan-Jian Hui, Hao Chen, Xing-Chun Peng, et al.
Oncotarget|October 14, 2015
The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusionQing-Kun Song, Jun Ren, Xin-Na Zhou, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
ACS Applied Materials & Interfaces|August 1, 2019
Bismuth Vacancy-Tuned Bismuth Oxybromide Ultrathin Nanosheets toward Photocatalytic CO<sub>2</sub> ReductionJun Di, Chao Chen, Chao Zhu, et al.
Scientific Reports|April 2, 2024
B-Myb deficiency boosts bortezomib-induced immunogenic cell death in colorectal cancerYuan-Jian Hui, Ting-Ting Yu, Liu-Gen Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 24, 2020
A Tandem 0D/2D/2D NbS<sub>2</sub> Quantum Dot/Nb<sub>2</sub> O<sub>5</sub> Nanosheet/g-C<sub>3</sub> N<sub>4</sub> Flake System with Spatial Charge-Transfer Cascades for Boosting Photocatalytic Hydrogen EvolutionBo Lin, Zihao Chen, Pin Song, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 30, 2013
HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitroXiao-Lin Lin, Xiao-Li Wang, Bo Ma, et al.
Experimental & Molecular Medicine|March 14, 2026
NRIP1 disrupts ERα signal in Sjögren's disease via AQP5 suppression and MYC-driven salivary dysfunctionBo Chen, Janak L Pathak, Xiuni Qin, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 24, 2003
[Phase II clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer]Shu-jun Liu, Li-jun Di, Jie Wang, et al.
The Journal of International Medical Research|January 12, 2023
The inflammatory cytokine profiles and ocular biometric characteristics of primary angle-closure glaucomaHong-Bo Zeng, Jun-Di Jiang, Rong Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 6, 2006
[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer]Lin Yang, Jin-wan Wang, Yan Sun, et al.
Photodiagnosis and Photodynamic Therapy|April 8, 2023
Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancerYuan-Jian Hui, Hao Chen, Xing-Chun Peng, et al.
Oncotarget|October 14, 2015
The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusionQing-Kun Song, Jun Ren, Xin-Na Zhou, et al.
Pageof 17